Acquisition of Cisplatin Resistance Shifts Head and Neck Squamous Cell Carcinoma Metabolism toward Neutralization of Oxidative Stress

Background: Cisplatin (CDDP) is commonly utilized in the treatment of advanced solid tumors including head and neck squamous cell carcinoma (HNSCC). Cisplatin response remains highly variable among individual tumors and development of cisplatin resistance is common. We hypothesized that development...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Wangjie, Chen, Yunyun, Putluri, Nagireddy, Coarfa, Cristian, Robertson, Matthew J., Putluri, Vasanta, Stossi, Fabio, Dubrulle, Julien, Mancini, Michael A., Pang, Jonathan C., Nguyen, Trung, Baluya, Dodge, Myers, Jeffrey N., Lai, Stephen Y., Sandulache, Vlad C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352569/
https://www.ncbi.nlm.nih.gov/pubmed/32599707
http://dx.doi.org/10.3390/cancers12061670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352569/
https://www.ncbi.nlm.nih.gov/pubmed/32599707
http://dx.doi.org/10.3390/cancers12061670

Ejemplares similares